mhurhangee/patent-ind-claim-en huggingface dataset:
A compound represented by formula , a salt thereof, or a solvate thereof: wherein substituents R 1 and R 2 are represented by the following case (a) or (b): (a) R 1 is optionally substituted phenyl, and R 2 is H, optionally substituted phenyl, or -C(O)NHR 3 where the R 3 is H, C 1-6 alkyl, or optionally substituted benzyl; or (b) R 1 is optionally substituted naphthyl or optionally substituted phenyl, and R 2 is optionally substituted phenyl or -C(O)NHR 4 where the R 4 is H, C 1-6 alkyl, or optionally substituted siloxybenzyl, and wherein the term "optionally substituted" means that the respective group is unsubstituted or has a substituent selected from H, halogen, nitro, amino, cyano, OH, C 1-6 alkyl, C 1-6 halogenoalkyl, C 1-6 hydroxyalkyl, C 1-6 alkylamino, C 3-6 cycloalkyl, C 2-6 alkenyl, C 2-6 halogenoalkenyl, C 2-6 hydroxyalkenyl, C 2-6 alkenylamino, C 3-6 cycloalkenyl, C 2-6 alkynyl, C 2-6 halogenoalkynyl, C 2-6 hydroxyalkynyl, C 2-6 alkynylamino, C 1-6 alkoxy, C 1-6 halogenoalkoxy, C 1-6 hydroxyalkoxy, C 1-6 alkoxyamino, C 1-6 alkoxyphenyl, trialkylsiloxy, alkyldiphenylsiloxy, aryl, heteroaryl, C 1-6 alkoxy-substituted C 1-6 alkoxy, C 1-6 alkoxyphenyl-substituted C 1-6 alkoxy, tri(C 1-6 alkylsiloxy)C 1-6 alkyl, C 1-6 alkyldiphenylsiloxy C 1-6 alkyl, triphenylsiloxy C 1-6 alkyl, tri(C 1-6 alkyl)siloxy, C 1-6 alkyldiphenylsiloxy, and triphenylsiloxy. wherein substituents R 1 and R 2 are represented by the following case (a) or (b): (a) R 1 is optionally substituted phenyl, and R 2 is H, optionally substituted phenyl, or -C(O)NHR 3 where the R 3 is H, C 1-6 alkyl, or optionally substituted benzyl; or (b) R 1 is optionally substituted naphthyl or optionally substituted phenyl, and R 2 is optionally substituted phenyl or -C(O)NHR 4 where the R 4 is H, C 1-6 alkyl, or optionally substituted siloxybenzyl, and (a) R 1 is optionally substituted phenyl, and R 2 is H, optionally substituted phenyl, or -C(O)NHR 3 where the R 3 is H, C 1-6 alkyl, or optionally substituted benzyl; or (b) R 1 is optionally substituted naphthyl or optionally substituted phenyl, and R 2 is optionally substituted phenyl or -C(O)NHR 4 where the R 4 is H, C 1-6 alkyl, or optionally substituted siloxybenzyl, and wherein the term "optionally substituted" means that the respective group is unsubstituted or has a substituent selected from H, halogen, nitro, amino, cyano, OH, C 1-6 alkyl, C 1-6 halogenoalkyl, C 1-6 hydroxyalkyl, C 1-6 alkylamino, C 3-6 cycloalkyl, C 2-6 alkenyl, C 2-6 halogenoalkenyl, C 2-6 hydroxyalkenyl, C 2-6 alkenylamino, C 3-6 cycloalkenyl, C 2-6 alkynyl, C 2-6 halogenoalkynyl, C 2-6 hydroxyalkynyl, C 2-6 alkynylamino, C 1-6 alkoxy, C 1-6 halogenoalkoxy, C 1-6 hydroxyalkoxy, C 1-6 alkoxyamino, C 1-6 alkoxyphenyl, trialkylsiloxy, alkyldiphenylsiloxy, aryl, heteroaryl, C 1-6 alkoxy-substituted C 1-6 alkoxy, C 1-6 alkoxyphenyl-substituted C 1-6 alkoxy, tri(C 1-6 alkylsiloxy)C 1-6 alkyl, C 1-6 alkyldiphenylsiloxy C 1-6 alkyl, triphenylsiloxy C 1-6 alkyl, tri(C 1-6 alkyl)siloxy, C 1-6 alkyldiphenylsiloxy, and triphenylsiloxy.
A system for reducing risk of infection at an implant fixation site comprising: a drug-eluting screw having a shaft having a threaded portion and a head disposed at a proximal end of the shaft , wherein the head defines a drive recess including a driver engagement region and a reservoir region ; a drug eluting component disposed within the reservoir region in a manner that does not substantially impair a connection between a driver and the screw when the driver is operably disposed within the driver engagement region ; the drug eluting component including a carrier matrix and a therapeutic agent including an antibiotic or a combination of multiple antibiotics, the therapeutic agent being at least 20% of the drug eluting component prior to implantation; and a fixation implant including at least one aperture configured for the shaft to be secured through the aperture to bone at a fracture site; wherein the drug eluting screw is configured to secure the fixation implant to the bone; and, wherein the drug eluting component is configured to elute the antibiotic locally at the surface of the fixation implant so as to reduce the risk of infection. a drug-eluting screw having a shaft having a threaded portion and a head disposed at a proximal end of the shaft , wherein the head defines a drive recess including a driver engagement region and a reservoir region ; a drug eluting component disposed within the reservoir region in a manner that does not substantially impair a connection between a driver and the screw when the driver is operably disposed within the driver engagement region ; the drug eluting component including a carrier matrix and a therapeutic agent including an antibiotic or a combination of multiple antibiotics, the therapeutic agent being at least 20% of the drug eluting component prior to implantation; and a fixation implant including at least one aperture configured for the shaft to be secured through the aperture to bone at a fracture site; wherein the drug eluting screw is configured to secure the fixation implant to the bone; and, wherein the drug eluting component is configured to elute the antibiotic locally at the surface of the fixation implant so as to reduce the risk of infection.
A method for producing a food product comprising hydrolysed starch, said method comprising the steps of : a) Providing a starting material which comprises both starch and at least one amylolytic enzyme, b) Providing as ingredients: water, at least one further amylolytic enzyme comprising amylase not endogenous to the provided starting material and optionally one or more other ingredients, c) Mixing the starting material of step a) and the ingredients of step b) d) adjusting the temperature of the mixture of step c) to a temperature which leads to gelatinization of the starch in said mixture and inactivation of the at least one amylolytic enzyme which was provided with the starting material in a), and e) simultaneously to step d), subjecting said mixture of step c) to high shear mixing, wherein said high shear mixing is achieved by use of a Ring Layer Mixer. f) Incubating the mixture of step e) such that the desired degree of hydrolysis is achieved, thereby obtaining a food product comprising hydrolysed starch. a) Providing a starting material which comprises both starch and at least one amylolytic enzyme, b) Providing as ingredients: water, at least one further amylolytic enzyme comprising amylase not endogenous to the provided starting material and optionally one or more other ingredients, c) Mixing the starting material of step a) and the ingredients of step b) d) adjusting the temperature of the mixture of step c) to a temperature which leads to gelatinization of the starch in said mixture and inactivation of the at least one amylolytic enzyme which was provided with the starting material in a), and e) simultaneously to step d), subjecting said mixture of step c) to high shear mixing, wherein said high shear mixing is achieved by use of a Ring Layer Mixer. f) Incubating the mixture of step e) such that the desired degree of hydrolysis is achieved,
Method for processing cigarette butts polluted with toxic substances comprising the steps: a. feeding a container with said cigarette butts, a possible organic substrate and water, obtaining a culture substrate according to a first predetermined ratio between said organic substrate and said cigarette butts; b. inoculating said culture substrate by at least one strain of fungus according to a second predetermined ratio between said at least one strain of fungus and said culture substrate; c. a mycelium growth phase of said at least one inoculated fungus strain in said culture substrate, obtaining a culture of said at least one fungus strain for a first predetermined period of time in which a first portion of toxic substances is degraded by the enzymatic activity secreted by said at least one cultured fungus strain; d. a fruiting phase of said culture of said at least one strain of fungus to form fruits of said at least one strain for a second predetermined period of time with a transfer of a second portion of toxic substances from the culture substrate in said fruits; e. collecting said fruits of said fungi; f. obtaining a culture substrate which is depolluted and cleared of said first portion of toxic substances and said second portion toxic substances; and g. drying said depolluted and cleared culture substrate and obtaining a biopolymer. a. feeding a container with said cigarette butts, a possible organic substrate and water, obtaining a culture substrate according to a first predetermined ratio between said organic substrate and said cigarette butts; b. inoculating said culture substrate by at least one strain of fungus according to a second predetermined ratio between said at least one strain of fungus and said culture substrate; c. a mycelium growth phase of said at least one inoculated fungus strain in said culture substrate, obtaining a culture of said at least one fungus strain for a first predetermined period of time in which a first portion of toxic substances is degraded by the enzymatic activity secreted by said at least one cultured fungus strain; d. a fruiting phase of said culture of said at least one strain of fungus to form fruits of said at least one strain for a second predetermined period of time with a transfer of a second portion of toxic substances from the culture substrate in said fruits; e. collecting said fruits of said fungi; f. obtaining a culture substrate which is depolluted and cleared of said first portion of toxic substances and said second portion toxic substances; and g. drying said depolluted and cleared culture substrate and obtaining a biopolymer.
An occlusive device comprising: a frame formed of a plurality of elongate members, having a delivery configuration and a deployed configuration, the frame being configured to collapse to the delivery configuration , the frame comprising a distal end and a proximal end, a tapered region , a proximal eyelet at the proximal end of the frame and a distal eyelet at the distal end of the frame; the occlusive device further comprising an occlusive face having a peripheral edge and a planar shape, the occlusive face positioned toward the proximal end of the frame , the occlusive face formed by the frame and a membrane at least partially covering the frame , the membrane being configured to inhibit the passage of blood; at least one anchor positioned at the peripheral edge of the occlusive face; and wherein the occlusive face is configured to conform, when in a deployed configuration, to a shape of an ostium of the left atrial appendage (LAA), and wherein the tapered region is configured to conform to a variable taper of an inner region of a LAA. a frame formed of a plurality of elongate members, having a delivery configuration and a deployed configuration, the frame being configured to collapse to the delivery configuration , the frame comprising a distal end and a proximal end, a tapered region , a proximal eyelet at the proximal end of the frame and a distal eyelet at the distal end of the frame; the occlusive device further comprising an occlusive face having a peripheral edge and a planar shape, the occlusive face positioned toward the proximal end of the frame , the occlusive face formed by the frame and a membrane at least partially covering the frame , the membrane being configured to inhibit the passage of blood; at least one anchor positioned at the peripheral edge of the occlusive face; and wherein the occlusive face is configured to conform, when in a deployed configuration, to a shape of an ostium of the left atrial appendage (LAA), and wherein the tapered region is configured to conform to a variable taper of an inner region of a LAA.
A vehicle comprising a first memory , a distress sensor system , a processing circuitry operatively connected to memory and the distress sensor system, wherein the memory comprises personal data linked to the user, wherein the processing circuitry is configured to protect data of a user in a vehicle in the event of distress by: detecting (S1) a signal of distress from the distress sensor system; in response to detecting the distress signal, automatically deleting (S2) the data linked to the user that is stored on the first memory; wherein the distress signal is received from a sensor in the vehicle in response to a detected crash of the vehicle. detecting (S1) a signal of distress from the distress sensor system; in response to detecting the distress signal, automatically deleting (S2) the data linked to the user that is stored on the first memory; wherein the distress signal is received from a sensor in the vehicle in response to a detected crash of the vehicle.
A phantom device for a dark field imaging system , the phantom device comprising: - a main body , reference parts formed of an attenuation part and a de-coherence part being stacked on the attenuation part, such that the attenuation part and the de-coherence part of the respective reference part are arranged consecutively along a predefined direction of the main body; wherein each de-coherence part is configured to cause de-coherence disturbance to an X-ray beam, if said X-ray beam passes the respective de-coherence part along the predefined direction; wherein each attenuation part is configured to cause attenuation disturbance to an X-ray beam, if said X-ray beam passes the respective attenuation part along the predefined direction; wherein the main body comprsises a first group of at least two reference parts ; wherein each of the de-coherence parts of the first group are configured to cause the same first degree of de-coherence disturbance; and wherein the attenuation parts of the first group are configured to cause mutually different degrees of attenuation disturbance. - a main body , reference parts formed of an attenuation part and a de-coherence part being stacked on the attenuation part, such that the attenuation part and the de-coherence part of the respective reference part are arranged consecutively along a predefined direction of the main body; wherein each de-coherence part is configured to cause de-coherence disturbance to an X-ray beam, if said X-ray beam passes the respective de-coherence part along the predefined direction; wherein each attenuation part is configured to cause attenuation disturbance to an X-ray beam, if said X-ray beam passes the respective attenuation part along the predefined direction; wherein the main body comprsises a first group of at least two reference parts ; wherein each of the de-coherence parts of the first group are configured to cause the same first degree of de-coherence disturbance; and wherein the attenuation parts of the first group are configured to cause mutually different degrees of attenuation disturbance.
A method of preparing an ASA graft copolymer, comprising: a) a seed preparation step, in which one or more monomers selected from an aromatic vinyl monomer, a vinyl cyan monomer, and an alkyl acrylate monomer are polymerized to prepare seeds; b) a core preparation step, in which an alkyl acrylate monomer is added in the presence of the prepared seeds, and polymerization is performed to prepare cores; and c) a shell preparation step, in which one or more monomers selected from an aromatic vinyl monomer and a vinyl cyan monomer and an emulsifier are added in the presence of the prepared cores, and graft polymerization is performed to prepare shells, wherein the emulsifier contains a multifunctional carboxylic acid having 30 to 55 carbon atoms or a salt thereof, and an average size of the prepared shells is 80 to 150 nm being larger than an average size of the cores, wherein the average size of particles was measured in Gaussian mode using dynamic laser light scattering. a) a seed preparation step, in which one or more monomers selected from an aromatic vinyl monomer, a vinyl cyan monomer, and an alkyl acrylate monomer are polymerized to prepare seeds; b) a core preparation step, in which an alkyl acrylate monomer is added in the presence of the prepared seeds, and polymerization is performed to prepare cores; and c) a shell preparation step, in which one or more monomers selected from an aromatic vinyl monomer and a vinyl cyan monomer and an emulsifier are added in the presence of the prepared cores, and graft polymerization is performed to prepare shells,
A humidifier that provides humidification to breathing gases for ventilating a patient, comprising: a first sensor that monitors an inspiratory flow of breathing gases upstream of an atomizer of the humidifier; a second sensor that monitors humidity information of the breathing gases upstream of the atomizer ; a processor that calculates, based on the inspiratory flow and the humidity information, an amount of water to add to the breathing gases to reach a desired humidity; and a controller that commands: the atomizer to deliver the amount of water in bursts of atomized water directly into a flow path of the breathing gases; and a heating element to heat a thermally-conductive material in the flow path downstream of the atomizer , wherein the atomized water is vaporized upon contact of the water with the thermally-conductive material to form humidified breathing gases for delivery to a patient being ventilated by the ventilator, wherein the atomizer comprises a hollow-cone atomizer . a first sensor that monitors an inspiratory flow of breathing gases upstream of an atomizer of the humidifier; a second sensor that monitors humidity information of the breathing gases upstream of the atomizer ; a processor that calculates, based on the inspiratory flow and the humidity information, an amount of water to add to the breathing gases to reach a desired humidity; and a controller that commands: the atomizer to deliver the amount of water in bursts of atomized water directly into a flow path of the breathing gases; and a heating element to heat a thermally-conductive material in the flow path downstream of the atomizer , wherein the atomized water is vaporized upon contact of the water with the thermally-conductive material to form humidified breathing gases for delivery to a patient being ventilated by the ventilator, wherein the atomizer comprises a hollow-cone atomizer . the atomizer to deliver the amount of water in bursts of atomized water directly into a flow path of the breathing gases; and a heating element to heat a thermally-conductive material in the flow path downstream of the atomizer , wherein the atomized water is vaporized upon contact of the water with the thermally-conductive material to form humidified breathing gases for delivery to a patient being ventilated by the ventilator, wherein the atomizer comprises a hollow-cone atomizer .
Insole for footwear, the insole comprising: - an anterior arch support ; and - an anterior reinforcing bridge having a raised section for providing resistance against compression of the anterior arch support ; wherein the anterior reinforcing bridge is convex as seen in an anterior direction of the insole . - an anterior arch support ; and - an anterior reinforcing bridge having a raised section for providing resistance against compression of the anterior arch support ;
Method for presenting a shared virtual environment to users residing in different vehicles while the vehicles are driving in a real-world environment , wherein in at least one of the vehicles - an interactive user device of that vehicle receives definition data from the respective user residing in that vehicle and/or generates the definition data in dependence on a current driving situation of the vehicle , wherein the definition data describe a new virtual event for the virtual environment , and - a position sensor of the vehicle generates position data of the vehicle while the definition data is generated, wherein the position data describe a current position of the vehicle in the real-world environment , and a stationary server unit receives the definition data and the corresponding position data from out of the vehicle and generates corresponding event data of the new virtual event , wherein in dependence on the position data a trigger region is defined that defines where in the real-world environment the virtual event shall be triggered, characterized in that the server unit receives respective request data from a user device of at least one of the other vehicles , wherein the request data indicate that the vehicle approaches or enters or is positioned in the respective trigger region of one of the virtual events , and the server unit sends the corresponding event data of that virtual event to the interactive user device of that vehicle and the corresponding virtual event is displayed to the user in that vehicle as a part of the virtual environment . - an interactive user device of that vehicle receives definition data from the respective user residing in that vehicle and/or generates the definition data in dependence on a current driving situation of the vehicle , wherein the definition data describe a new virtual event for the virtual environment , and - a position sensor of the vehicle generates position data of the vehicle while the definition data is generated, wherein the position data describe a current position of the vehicle in the real-world environment , and a stationary server unit receives the definition data and the corresponding position data from out of the vehicle and generates corresponding event data of the new virtual event , wherein in dependence on the position data a trigger region is defined that defines where in the real-world environment the virtual event shall be triggered, characterized in that the server unit receives respective request data from a user device of at least one of the other vehicles , wherein the request data indicate that the vehicle approaches or enters or is positioned in the respective trigger region of one of the virtual events , and the server unit sends the corresponding event data of that virtual event to the interactive user device of that vehicle and the corresponding virtual event is displayed to the user in that vehicle as a part of the virtual environment .